News Headlines Article

FDA approves new heart failure pill from Novartis
Modern Healthcare

Government regulators have approved a new pill from Novartis to treat heart failure.The Food and Drug Administration approved the combination drug, Entresto, based on studies showing it reduced rates of heart-related death and hospitalization compared with older drugs.More than 5 million Americans and more than 25 million people worldwide have heart failure, a disease that causes the heart to gradually lose its pumping power. It kills up to half of patients within five years, despite numerous generic pills and other treatments available.